Prospera Financial Services’s Viking Therapeutics VKTX Stock Holding History

Prospera Financial Services’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$268K	Buy	9,842 +61	+0.6%	+$2.11K	﹤0.01%	1308
2026 Q2	$382K	Buy	9,781 +506	+5%	+$16.3K	0.01%	1152
2026 Q1	$302K	Sell	9,275 -90	-1%	-$2.89K	﹤0.01%	1202
2025 Q4	$329K	Buy	9,365 +455	+5%	+$16.1K	0.01%	1115
2025 Q3	$234K	Buy	+8,910	New	+$266K	﹤0.01%	1234
2025 Q1	–	Sell	-5,331	Closed	-$215K	–	1235
2024 Q4	$215K	Buy	5,331 +624	+13%	+$35.6K	0.01%	1061
2024 Q3	$298K	Buy	+4,707	New	+$276K	0.01%	923
2024 Q2	–	Sell	-3,565	Closed	-$292K	–	1188
2024 Q1	$292K	Buy	+3,565	New	+$159K	0.01%	910

Other funds holding VKTX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Prospera Financial Services's VKTX Position: Q3 2026 in Review

Prospera Financial Services increased its Viking Therapeutics (VKTX) stake by 0.62% in Q3 2026, buying an estimated $2.11K and bringing the position to 9,842 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

Prospera Financial Services first reported a position in VKTX in Q1 2024 and has held it in 8 quarters since. The position peaked at $382K in Q2 2026. 185 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

Prospera Financial Services held 9,842 shares of Viking Therapeutics worth $268K as of Q3 2026.
Prospera Financial Services bought 61 Viking Therapeutics shares in Q3 2026, an estimated $2.11K.
Viking Therapeutics made up ﹤0.01% of Prospera Financial Services's portfolio in Q3 2026, its #1308 holding.
Prospera Financial Services first reported a position in Viking Therapeutics in Q1 2024 and has held it in 8 quarters since.
Prospera Financial Services's Viking Therapeutics position peaked at $382K in Q2 2026.
185 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Prospera Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.